"La Polyclinique Bordeaux Rive Droite est un établissement de type MCO (Médecine, Chirurgie, Obstétrique) appartenant à GBNA Polycliniques, groupe de santé privé familial et médical sur la région Nouvelle-Aquitaine. La polyclinique est le fruit du regroupement de deux établissements, un se trouvant sur le site actuel, la clinique des 4 pavillons, et un se trouvant à Cenon – la clinique de la rive droite. L’établissement dispose de 260 lits et places avec près de 400 collaborateurs et une centaine de médecins. Aujourd’hui la Polyclinique propose aux habitants de la Rive Droite une proximité et une offre de soins pluridisciplinaire avec toutes les chirurgies pratiquées hormis la cardiologie et la neurologie."

During the past decade, Polyclinique des Quatre Pavillons conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Polyclinique des Quatre Pavillons" #1 sponsor was "UNICANCER" with 8 trials, followed by "GERCOR - Multidisciplinary Oncology Cooperative Group" with 5 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 2 trials sponsored, "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials sponsored and "ARCAGY/ GINECO GROUP" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Polyclinique des Quatre Pavillons" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "DePuy Synthes" with 1 trials as a collaborator, "LDR Médical" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Polyclinique des Quatre Pavillons" are "Colorectal Cancer" (6 trials), "Pancreatic Cancer" (4 trials), "Prostate Cancer" (3 trials), "ALK Gene Mutation" (1 trials) and "Arthroplasty, Hip, Replacement" (1 trials). Many other conditions were trialed in "Polyclinique des Quatre Pavillons" in a lesser frequency.

Most popular intervention types in "Polyclinique des Quatre Pavillons" are "Drug" (16 trials), "Procedure" (7 trials), "Radiation" (7 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (6 trials), "fluorouracil" (5 trials), "capecitabine" (4 trials), "docetaxel" (4 trials) and "oxaliplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Polyclinique des Quatre Pavillons" are 15 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Polyclinique des Quatre Pavillons". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Polyclinique des Quatre Pavillons, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Polyclinique des Quatre Pavillons, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".